A detailed history of Hsbc Holdings PLC transactions in Axonics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 328,339 shares of AXNX stock, worth $23.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
328,339
Previous 322,853 1.7%
Holding current value
$23.3 Million
Previous $21.7 Million 5.39%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.3 - $69.67 $369,207 - $382,209
5,486 Added 1.7%
328,339 $22.9 Million
Q2 2024

Aug 12, 2024

BUY
$66.47 - $69.65 $4.49 Million - $4.71 Million
67,603 Added 26.49%
322,853 $21.7 Million
Q1 2024

May 15, 2024

BUY
$56.67 - $69.36 $10.8 Million - $13.2 Million
189,756 Added 289.73%
255,250 $17.6 Million
Q4 2023

Feb 12, 2024

BUY
$49.38 - $63.75 $678,184 - $875,542
13,734 Added 26.53%
65,494 $4.08 Million
Q3 2023

Nov 13, 2023

BUY
$48.64 - $62.51 $110,510 - $142,022
2,272 Added 4.59%
51,760 $2.9 Million
Q2 2023

Aug 11, 2023

SELL
$47.99 - $60.21 $31,289 - $39,256
-652 Reduced 1.3%
49,488 $2.5 Million
Q1 2023

May 15, 2023

SELL
$52.6 - $67.34 $9,625 - $12,323
-183 Reduced 0.36%
50,140 $2.74 Million
Q4 2022

Feb 14, 2023

BUY
$59.56 - $76.6 $81,895 - $105,324
1,375 Added 2.81%
50,323 $3.15 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $159,853 - $215,454
2,758 Added 5.97%
48,948 $3.45 Million
Q2 2022

Aug 11, 2022

BUY
$39.5 - $64.42 $144,372 - $235,455
3,655 Added 8.59%
46,190 $2.62 Million
Q1 2022

May 16, 2022

BUY
$43.74 - $62.76 $140,230 - $201,208
3,206 Added 8.15%
42,535 $2.66 Million
Q4 2021

Feb 11, 2022

BUY
$50.01 - $73.35 $562,762 - $825,407
11,253 Added 40.08%
39,329 $2.2 Million
Q3 2021

Nov 12, 2021

BUY
$59.21 - $78.66 $1.66 Million - $2.21 Million
28,076 New
28,076 $1.83 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.